| A generalizable decision-making framework for selecting onsite versus send-out clinical laboratory testing LF Schroeder, P Rebman, P Kasaie, E Kenu, J Zelner, DW Dowdy Medical Decision Making 44 (3), 307-319, 2024 | | 2024 |
| The Impact of Preventive Treatment for Multidrug-and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates P Kasaie, J Pennington, A Gupta, DW Dowdy, EA Kendall Clinical Infectious Diseases 78 (1), 133-143, 2024 | | 2024 |
| The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study KN Althoff, C Stewart, E Humes, L Gerace, C Boyd, K Gebo, AC Justice, ... PLoS medicine 21 (1), e1004325, 2024 | 3 | 2024 |
| Evaluating Clinic-Based Interventions to Reduce Racial Differences in Mortality Among People With Human Immunodeficiency Virus in the United States LC Zalla, SR Cole, JJ Eron, AA Adimora, AI Vines, KN Althoff, VC Marconi, ... The Journal of Infectious Diseases 228 (12), 1690-1698, 2023 | | 2023 |
| Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving … P Kasaie, C Stewart, E Humes, L Gerace, EP Hyle, LC Zalla, PF Rebeiro, ... Annals of epidemiology 87, 69-78. e32, 2023 | | 2023 |
| The testing imperative: why the US ending the human immunodeficiency virus (HIV) epidemic program needs to renew efforts to expand HIV testing in clinical and community-based … B Nosyk, AT Fojo, P Kasaie, B Enns, L Trigg, M Piske, AB Hutchinson, ... Clinical Infectious Diseases 76 (12), 2206-2208, 2023 | 2 | 2023 |
| The Testing Imperative: Why the US Ending the HIV Epidemic Program Needs to Renew Efforts to Expand Human Immunodeficiency Virus Testing in Clinical and Community-based Settings B Nosyk, AT Fojo, P Kasaie, B Enns, L Trigg, M Piske, AB Hutchinson, ... CLINICAL INFECTIOUS DISEASES, 2023 | | 2023 |
| The testing imperative: Why the US EHE needs to renew efforts to expand HIV testing in clinical and community-based settings. B Nosyk, AT Fojo, P Kasaie, B Enns, L Trigg, M Piske, AB Hutchinson, ... Clinical Infectious Diseases: an Official Publication of the Infectious …, 2023 | | 2023 |
| Trials underestimate the impact of preventive treatment for household contacts exposed to multidrug-resistant tuberculosis: a simulation study P Kasaie, J Pennington, A Gupta, DW Dowdy, EA Kendall medRxiv, 2023.02. 06.23285528, 2023 | | 2023 |
| A growing number of men who have sex with men aging with HIV (2021–2031): a comparison of two microsimulation models EP Hyle, P Kasaie, E Schwamm, C Stewart, E Humes, KP Reddy, ... The Journal of infectious diseases 227 (3), 412-422, 2023 | 2 | 2023 |
| The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030 KN Althoff, C Stewart, E Humes, L Gerace, C Boyd, K Gebo, AC Justice, ... medRxiv, 2022.11. 04.22281891, 2022 | | 2022 |
| Abuse in the continua: HIV prevention and care outcomes and syndemic conditions associated with intimate partner violence among black gay and bisexual men in the southern … AL Wirtz, PA Burns, T Poteat, M Malik, JJ White, D Brooks, P Kasaie, ... AIDS and Behavior 26 (11), 3761-3774, 2022 | 6 | 2022 |
| Projected impact of expanded long-acting injectable PrEP use among men who have sex with men on local HIV epidemics R Balasubramanian, P Kasaie, M Schnure, DW Dowdy, M Shah, AT Fojo JAIDS Journal of Acquired Immune Deficiency Syndromes 91 (2), 144-150, 2022 | 7 | 2022 |
| Five-year mortality for adults entering human immunodeficiency virus care under universal early treatment compared with the general US population JK Edwards, SR Cole, TL Breger, LM Filiatreau, L Zalla, GE Mulholland, ... Clinical Infectious Diseases 75 (5), 867-874, 2022 | 9 | 2022 |
| Potential effects of the coronavirus disease 2019 (COVID-19) pandemic on human immunodeficiency virus (HIV) transmission: a modeling study in 32 US cities A Fojo, E Wallengren, M Schnure, DW Dowdy, M Shah, P Kasaie Clinical Infectious Diseases 75 (1), e1145-e1153, 2022 | 7 | 2022 |
| The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons with HIV Engaged in Care in the NA-ACCORD A Chandran, X Feng, SB Coburn, P Kasaie, J Malone, MA Horberg, ... JAIDS Journal of Acquired Immune Deficiency Syndromes, 10.1097, 2022 | | 2022 |
| PROJECTED IMPACT OF EXPANDED LONG-ACTING INJECTABLE PrEP USE ON LOCAL HIV EPIDEMICS R Balasubramanian Proceedings of the Conference on Retroviruses and Opportunisitc Infections …, 2022 | 1 | 2022 |
| Forecasting the effect of HIV-targeted interventions on the age distribution of people living with HIV: a case study from Kenya MC Schnure, P Kasaie, DW Dowdy, BL Genberg, EA Kendall, AT Fojo AIDS, 10.1097, 2022 | 2 | 2022 |
| The shifting age distribution of people with HIV using antiretroviral therapy in the United States KN Althoff, CN Stewart, E Humes, J Zhang, L Gerace, CM Boyd, C Wong, ... AIDS 36 (3), 459-471, 2022 | 25 | 2022 |
| Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States P Kasaie, C Stewart, E Humes, L Gerace, J Zhang, MJ Silverberg, ... Annals of epidemiology 65, 46-55, 2022 | 8 | 2022 |
David DowdyProfessor of Epidemiology & Vice Dean for Education, Johns Hopkins Bloomberg School of Public HealthVerified email at jhsph.edu
